Page last updated: 2024-08-23

dobutamine and Muscular Dystrophy, Duchenne

dobutamine has been researched along with Muscular Dystrophy, Duchenne in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyers, TA; Townsend, D1
Fischer, G; Stephani, U; van Baalen, A; von Spiczak, S1
Bauer, R; Blain, A; Bushby, K; Greally, E; Laval, S; Lochmüller, H; MacGowan, GA; Straub, V1
Beltramo, F; Bosser, G; Burger, G; Lethor, JP; Lucron, H; Marçon, F; Marie, PY1
Day, SM; Favre, EG; Metzger, JM; Michele, DE; Townsend, D; Yasuda, S1
Barber, BJ; Benson, DW; Cripe, LH; Markham, LW; Spicer, RL; Weidner, N; Wong, BL1
Allen, JM; Blankinship, MJ; Chamberlain, JS; Gregorevic, P; Metzger, JM; Townsend, D1

Other Studies

7 other study(ies) available for dobutamine and Muscular Dystrophy, Duchenne

ArticleYear
Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.
    American journal of physiology. Heart and circulatory physiology, 2015, Feb-15, Volume: 308, Issue:4

    Topics: Animals; Cardiotonic Agents; Dobutamine; Dystrophin; Fibrosis; Heart Ventricles; Hemodynamics; Mice; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardial Contraction; Ventricular Function, Right

2015
Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
    Neuromuscular disorders : NMD, 2008, Volume: 18, Issue:12

    Topics: Adolescent; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Infusions, Intravenous; Male; Muscular Dystrophy, Duchenne; Time Factors

2008
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.
    European journal of heart failure, 2010, Volume: 12, Issue:11

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dobutamine; Heart Failure; Hemodynamics; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Inbred Strains; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Papillary Muscles

2010
Evidence of early impairments in both right and left ventricular inotropic reserves in children with Duchenne's muscular dystrophy.
    The American journal of cardiology, 2004, Mar-15, Volume: 93, Issue:6

    Topics: Adolescent; Child; Dobutamine; Female; Humans; Male; Muscular Dystrophy, Duchenne; Radionuclide Ventriculography; Retrospective Studies; Ventricular Dysfunction, Left

2004
Dystrophic heart failure blocked by membrane sealant poloxamer.
    Nature, 2005, Aug-18, Volume: 436, Issue:7053

    Topics: Animals; Calcium; Cardiomyopathies; Dobutamine; Dystrophin; Hemodynamics; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardial Contraction; Myocytes, Cardiac; Poloxamer

2005
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Neuromuscular disorders : NMD, 2006, Volume: 16, Issue:11

    Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Disease Progression; Dobutamine; Dose-Response Relationship, Drug; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Muscular Dystrophy, Duchenne; Palliative Care; Quality of Life; Time Factors

2006
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2007, Volume: 15, Issue:6

    Topics: Adrenergic beta-Agonists; Animals; Blotting, Western; Cardiomyopathies; Dependovirus; Dobutamine; Dystrophin; Fluorescent Antibody Technique; Genetic Therapy; Genetic Vectors; Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardium

2007